(Telestock) – Valtecnea company listed on Euronext Growth Milan that operates in the sector of high-precision mechanics for medical devices and industrial applications, has closed the first semester of 2024 with Sales revenues equal to 17.1 million euros, up 0.3% compared to the same period of the previous year (equal to 17 million).
The data reflect the company’s consolidation path towards a Medical sector-oriented business mixwhich reached 68.3% of total revenues. The Industrial business line recorded a decline of 21.9%, mainly influenced by the current macroeconomic conditions.
“The first half of 2024 confirmed the solidity of our strategy and the ability to seize market opportunities – commented theCEO Paolo Mainetti – Total revenues remained stable compared to the same period last year, driven by a significant growth of 15.7% in the medical sector, which now represents more than two-thirds of our total revenues. This positive performance is in line with our strategy of focusing on the medical sector, a continuously expanding market”.
“During the first half of the year, to strengthen our presence in this strategic segment, we have undertaken several commercial activities, including participation in the MedTecLIVE fair to promote new precision mechanics solutions for orthopedics – he explained – At the same time, the industrial sector has recorded a contraction, in line with the current macroeconomic conditions of the European manufacturing sector. We look to the 2024 as a crucial year to consolidate and lay the foundations for sustainable and long-lasting growth”.